文献速递脑血管病

经头皮-颅骨-硬脑膜轴调控小鼠脑出血后脑损伤

Modulation of Brain Injury After Intracerebral Hemorrhage via the Scalp-Skull-Dura Interface in Mice.
PubMed 文献 · Stroke · 2026-09-10

本研究在小鼠脑出血模型中发现,颅骨骨髓来源的中性粒细胞比股骨骨髓来源者更具促炎和迁移特征,且优先迁移至硬脑膜和脑实质。头皮皮下给予CXCR2拮抗剂SB225002或硬脑膜给予抗CCL3中和抗体,均可减少中性粒细胞浸润、减轻脑水肿和血脑屏障破坏,并改善神经功能。靶向头皮-颅骨-硬脑膜界面可能成为减轻脑出血后脑损伤的可及策略。

要点

  • 颅骨骨髓中性粒细胞比股骨骨髓来源者促炎和迁移基因签名更强。
  • 脑出血后颅骨来源中性粒细胞优先迁移至硬脑膜和脑实质。
  • 皮下CXCR2拮抗剂或硬脑膜抗CCL3抗体可减轻脑损伤并改善神经功能。

核心结论

  • 颅骨骨髓可能是驱动脑出血后神经炎症的致病性中性粒细胞的主要来源。
  • 靶向头皮-颅骨-硬脑膜界面是减轻脑出血诱导脑损伤的可及策略。

研究设计与样本

  • 研究在雄性C57BL/6J小鼠中通过胶原酶注射诱导脑出血。
  • 对假手术和脑出血小鼠的颅骨骨髓与股骨骨髓进行单细胞RNA测序。
  • 采用流式细胞术和细胞示踪实验评估中性粒细胞在颅骨骨髓、硬脑膜和脑中的时间依赖性积累及来源贡献。

主要发现

  • 单细胞RNA测序显示脑出血使颅骨骨髓和股骨骨髓的造血均向髓系偏移,但颅骨骨髓中性粒细胞的促炎和迁移基因签名显著强于股骨骨髓中性粒细胞。
  • 脑出血后颅骨来源中性粒细胞优先迁移至硬脑膜和脑实质。
  • 皮下递送SB225002减少中性粒细胞浸润、减轻脑水肿和血脑屏障破坏,并改善短期和长期神经功能缺损。
  • 脑出血后硬脑膜中性粒细胞中CCL3特异性上调。
  • 硬脑膜递送抗CCL3抗体显著减少脑中中性粒细胞积累并保护免受脑出血诱导的脑损伤,伴随颅骨骨髓而非股骨骨髓中性粒细胞活化抑制。

临床怎么用

  • 经头皮皮下给予CXCR2拮抗剂或经硬脑膜给予抗CCL3中和抗体,可能通过阻断颅骨骨髓来源中性粒细胞迁移来减轻脑出血后脑损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuroinflammation critically contributes to secondary brain injury after intracerebral hemorrhage (ICH). The skull-dura interface allows immune trafficking from skull bone marrow (SBM) to the brain, but its role in ICH remains unclear. METHODS: ICH was induced in male C57BL/6J mice by collagenase injection. To compare the immune landscape of SBM and femur bone marrow (FBM), single-cell RNA sequencing was performed on sham-operated and ICH mice. Flow cytometry at serial time points, combined with cell-tracking experiments, was used to assess time-dependent neutrophil accumulation in SBM, dura, and brain, as well as the relative contribution of SBM- versus FBM-derived neutrophils after ICH. To test whether SBM-derived neutrophil migration contributes to neuroinflammation, the CXCR2 (C-X-C motif chemokine receptor 2) antagonist SB225002 was delivered subscalp. Finally, dural delivery of anti-CCL3 (C-C motif chemokine ligand 3) neutralizing antibodies was performed to determine the role of dural CCL3 in SBM neutrophil priming. Outcomes included evaluations of behavioral deficits, brain edema, integrity of the blood-brain barrier, hematoma removal, and brain neutrophil infiltration. RESULTS: Single-cell RNA sequencing revealed that ICH shifted hematopoiesis toward the myeloid lineage in both SBM and FBM; however, SBM neutrophils exhibited significantly stronger proinflammatory and migratory gene signatures than FBM neutrophils. Skull-derived neutrophils preferentially migrated to the dura and brain parenchyma post-ICH. Subscalp delivery of SB225002 reduced neutrophil infiltration, attenuated brain edema and blood-brain barrier disruption, and improved short-term and long-term neurological deficits. In addition, CCL3 was specifically upregulated in dural neutrophils after ICH. Unexpectedly, dural delivery of an anti-CCL3 antibody markedly reduced neutrophil accumulation in the brain and protected against ICH-induced brain injury, accompanied by inhibition of neutrophil activation in SBM but not in FBM. CONCLUSIONS: SBM may serve as a primary source of pathogenic neutrophils driving neuroinflammation after ICH. Targeting this immune compartment through the scalp-skull-dura interface represents an accessible strategy for mitigating ICH-induced brain injury.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Li P, Deng Z, Meng L, et al. Modulation of Brain Injury After Intracerebral Hemorrhage via the Scalp-Skull-Dura Interface in Mice. Stroke. 2026. PMID: 42717864. doi:10.1161/STROKEAHA.126.056286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。